Table 4.
Impact of acute GVHD and chronic GVHD on disease progression
CR1/CR2 N=164 | Non-CR1/CR2 N=101 | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
History of aGVHD II-IV | 1.7 | 0.8-3.6 | 0.2 | 0.5 | 0.2-1.2 | 0.1 |
History of aGVHD III-IV | No Events* | 0.3 | 1.2 | 0.3-5.0 | 0.8 | |
cGVHD (as time-dependent variable) | 0.3 | 0.1-0.8 | 0.02 | 0.6 | 0.3-1.3 | 0.2 |
Bivariate analysis cGVHD and T-lymphocyte chimerism | HR | 95% CI | P | HR | 95% CI | P |
---|---|---|---|---|---|---|
cGVHD (as time-dependent variable) | 0.3 | 0.1-0.8 | 0.02 | 0.6 | 0.3-1.3 | 0.2 |
Chimerism ≤ 85% | 2.2 | 1.1-4.6 | 0.03 | 1.2 | 0.5-2.9 | 0.6 |
No events in 2 patients with grade III-IV aGVHD